Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site

被引:75
作者
Julien, Jean-Philippe [1 ]
Bryson, Steve [1 ,2 ]
Nieva, Jose L. [3 ]
Pai, Emil F. [1 ,2 ,4 ,5 ]
机构
[1] Univ Toronto, Dept Biochem, Kings Coll Circle 1, Toronto, ON M5S 1A8, Canada
[2] Princess Margaret Hosp, Ontario Canc Inst, Div Canc Genom & Proteom, MaRS TMDT, Toronto, ON M5G 1L7, Canada
[3] Univ Basque Country, Dept Bioquim & Biol Mol, Unidad Biofis CSIC UPV EHU, Bilbao 48080, Spain
[4] Univ Toronto, Dept Med Biophys, Kings Coll Circle 1, Toronto, ON M5S 1A8, Canada
[5] Univ Toronto, Dept Mol Genet, Kings Coll Circle 1, Toronto, ON M5S 1A8, Canada
关键词
HIV-1; X-ray crystallography; bnmAb; 2F5; CDR H3 extended loop; epitope conformation;
D O I
10.1016/j.jmb.2008.09.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2F5 is a monoclonal antibody with potent and broadly neutralizing activity against HIV-1. It targets the membrane-proximal external region (MPER) of the gp41 subunit of the envelope glycoprotein and interferes with the process of fusion between viral and host cell membranes. This study presents eight 2F5 Fab' crystal structures in complex with various gp41 peptide epitopes. These structures reveal several key features of this antibody-antigen interaction. (1) Whenever free of contacts caused by crystal artifacts, the extended complementarity-determining region H. 3 loop is mobile; this is true for ligand-free and epitope-bound forms. (2) The interaction between the antibody and the gp41 ELDKWA epitope core is absolutely critical, and there are also close and specific contacts with residues located N-terminal to the epitope core. (3) Residues located at the C-terminus of the gp41. ELDKWA core do not interact as tightly with the antibody. However, in the presence of a larger peptide containing the gp41 fusion peptide segment, these residues adopt a conformation consistent with the start of an a-helix. (4) At high sulfate concentrations, the electron density maps of 2F5 F-ab'-peptide complexes contain a peak that may mark a binding site for phosphate groups of negatively charged lipid headgroups. The refined atomic-level details of 2F5 paratope-epitope interactions revealed here should contribute to a better understanding of the mechanism of 2F5-based virus neutralization, in general, and prove important for the design of potential vaccine candidates intended to elicit 2F5-like antibody production. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:377 / 392
页数:16
相关论文
共 52 条
  • [31] AMORE - AN AUTOMATED PACKAGE FOR MOLECULAR REPLACEMENT
    NAVAZA, J
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1994, 50 : 157 - 163
  • [32] Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
    Ofek, G
    Tang, M
    Sambor, A
    Katinger, H
    Mascola, JR
    Wyatt, R
    Kwong, PD
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (19) : 10724 - 10737
  • [33] Processing of X-ray diffraction data collected in oscillation mode
    Otwinowski, Z
    Minor, W
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 : 307 - 326
  • [34] Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5
    Ou, W
    Lu, N
    Yu, SS
    Silver, J
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (05) : 2539 - 2547
  • [35] PAI E, 2000, Patent No. 006168
  • [36] Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5
    Parker, CE
    Deterding, LJ
    Hager-Braun, C
    Binley, JM
    Schülke, N
    Katinger, H
    Moore, JP
    Tomer, KB
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (22) : 10906 - 10911
  • [37] A BROADLY NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY AGAINST GP41 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PURTSCHER, M
    TRKOLA, A
    GRUBER, G
    BUCHACHER, A
    PREDL, R
    STEINDL, F
    TAUER, C
    BERGER, R
    BARRETT, N
    JUNGBAUER, A
    KATINGER, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1651 - 1658
  • [38] HIV-1 gp41 as a target for viral entry inhibition
    Root, MJ
    Steger, HK
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (15) : 1805 - 1825
  • [39] Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody
    Sánchez-Martínez, S
    Lorizate, M
    Katinger, H
    Kunert, R
    Basañez, G
    Nieva, JL
    [J]. FEBS LETTERS, 2006, 580 (09): : 2395 - 2399
  • [40] Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies
    Sanchez-Martinez, Silvia
    Lorizate, Maier
    Katinger, Hermann
    Kunert, Renate
    Nieva, Jose L.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (10) : 998 - 1006